Wednesday, October 26, 2005; A03
“The government will back down from a plan to require long-term studies of new psychiatric drugs before allowing them on the market, regulators said yesterday.
The reversal of the recently adopted policy came after a panel of experts unanimously recommended against requiring such studies as a condition of approval. While such studies are needed, the experts said, delaying decisions on new medications would hurt patients.”
How paternalistically thoughtful of the FDA to think of the patient first!
Go Here

Jenny Hatch